Cost Consequence Analysis Of Apixaban Versus Warfarin In Patients With Atrial Fibrillation In The Mexican Public Health Sector
May 1, 2014, 00:00
10.1016/j.jval.2014.03.636
https://www.valueinhealthjournal.com/article/S1098-3015(14)00687-1/fulltext
Title :
Cost Consequence Analysis Of Apixaban Versus Warfarin In Patients With Atrial Fibrillation In The Mexican Public Health Sector
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00687-1&doi=10.1016/j.jval.2014.03.636
First page :
A109
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
64